Experiments for taxon Ganoderma tsugae (GANODERMATACEAE)

51 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
713539	PHARMACOLOGY OF EXTRACT - IN VITRO	IMMUNOMODULATOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)
151345	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-III-2-A
151338	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-I-0
421991	PHARMACOLOGY OF EXTRACT - IN VIVO	NATURAL KILLER CELL ENHANCEMENT	Ganoderma tsugae (GANODERMATACEAE)
713540	PHARMACOLOGY OF EXTRACT - IN VITRO	IMMUNOMODULATOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)
151341	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-II-1
252421	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ganoderma tsugae (GANODERMATACEAE)	ERGOSTA-6-22-DIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPI-DIOXY:
684342	PHARMACOLOGY OF EXTRACT - IN VITRO	SUPEROXIDE SCAVENGING ACTIVITY INCREASE	Ganoderma tsugae (GANODERMATACEAE)
605414	PHARMACOLOGY OF COMPOUND - IN VIVO	ANTIHEPATOTOXIC ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	LUCIDONE ALUCIDENOLGANODERIC ACID C-2GANODERIC ACID B
252419	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Ganoderma tsugae (GANODERMATACEAE)	ERGOSTA-6-9(11)-22-TRIEN-3-BETA-OL,5-ALPHA-8-ALPHA-EPI-DIOXY:
184562	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FA-1-B-ALPHA
151348	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-III-2-B
184558	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FI-O-A
215342	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Ganoderma tsugae (GANODERMATACEAE)	LANOSTA-8-24-DIEN-21-OIC ACID,5-ALPHA: 3-BETA-HYDROXY:
151337	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-I-0
760092	ISOLATION AND IDENTIFICATION OF		Ganoderma tsugae (GANODERMATACEAE)	GANODERIC ACID CGANODERIC ACID AGANODERIC ACID DGANODERIC ACID B
151344	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-III-2
151340	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FA-1
223739	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Ganoderma tsugae (GANODERMATACEAE)	ERGOSTA-7-22-DIENE,5-ALPHA: 2-BETA-3-ALPHA-9-ALPHA-TRIHYDROXY:
184559	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FI-O-B-ALPHA:
223740	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL CYCLE BLOCKING EFFECT	Ganoderma tsugae (GANODERMATACEAE)	ERGOSTA-7-22-DIENE,5-ALPHA: 2-BETA-3-ALPHA-9-ALPHA-TRIHYDROXY:
421992	PHARMACOLOGY OF EXTRACT - IN VIVO	NATURAL KILLER CELL ENHANCEMENT	Ganoderma tsugae (GANODERMATACEAE)
252418	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Ganoderma tsugae (GANODERMATACEAE)	TSUGARIOSIDE B
684343	PHARMACOLOGY OF EXTRACT - IN VITRO	PEROXIDE FORMATION INHIBITION	Ganoderma tsugae (GANODERMATACEAE)
151350	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE
151349	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE
184561	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FA-1-B-ALPHA
215341	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Ganoderma tsugae (GANODERMATACEAE)	TSUGARIC ACID ATSUGARIC ACID B
223737	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Ganoderma tsugae (GANODERMATACEAE)	LANOSTA-8-24-DIEN-21-OIC ACID,5-ALPHA: 3-ALPHA-ACETOXY:
151343	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-III-2
151347	ISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-III-2-B
943068	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)
684339	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)
421993	PHARMACOLOGY OF EXTRACT - IN VIVO	NATURAL KILLER CELL ENHANCEMENT	Ganoderma tsugae (GANODERMATACEAE)
184560	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FI-O-B-ALPHA:
151339	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FA-1
252417	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Ganoderma tsugae (GANODERMATACEAE)	TSUGARIC ACID C
409829	PHARMACOLOGY OF COMPOUND - IN VIVOISOLATION OF A COMPOUND WITH NOVEL STRUCTUREPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA TSUGAE ANTIBIOTIC
223738	PHARMACOLOGY OF COMPOUND - IN VITRO	APOPTOSIS INDUCTION	Ganoderma tsugae (GANODERMATACEAE)	LANOSTA-8-24-DIEN-21-OIC ACID,5-ALPHA: 3-ALPHA-ACETOXY:
151346	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-III-2-A
252420	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Ganoderma tsugae (GANODERMATACEAE)	TSUGARIOSIDE C
184557	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE FI-O-A
713541	PHARMACOLOGY OF EXTRACT - IN VITRO	IMMUNOMODULATOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)
684344	PHARMACOLOGY OF EXTRACT - IN VITRO	LIPID PEROXIDE FORMATION INHIBITION	Ganoderma tsugae (GANODERMATACEAE)
713542	PHARMACOLOGY OF EXTRACT - IN VITRO	IMMUNOMODULATOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)
684340	PHARMACOLOGY OF EXTRACT - IN VITRO	CHELATING EFFECT(IRON)	Ganoderma tsugae (GANODERMATACEAE)
684341	PHARMACOLOGY OF EXTRACT - IN VITRO	RADICAL SCAVENGING EFFECT	Ganoderma tsugae (GANODERMATACEAE)
151342	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTITUMOR ACTIVITY	Ganoderma tsugae (GANODERMATACEAE)	GANODERMA POLYSACCHARIDE F-II-1
215343	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION AND IDENTIFICATION OF		Ganoderma tsugae (GANODERMATACEAE)	LANOSTA-8-24-DIEN-21-OIC ACID,5-ALPHA: 3-OXO:
421994	PHARMACOLOGY OF EXTRACT - IN VIVO	INTERFERON INDUCTION STIMULATION	Ganoderma tsugae (GANODERMATACEAE)
605413	ISOLATION AND IDENTIFICATION OF		Ganoderma tsugae (GANODERMATACEAE)	LUCIDONE ALUCIDENOLGANODERIC ACID C-2GANODERIC ACID B

Experiments for taxon Ganoderma tsugae (GANODERMATACEAE)

Experiments (51 results)

Filters

Worktypes (15)

Pharmacology (15)

Compounds (30)

Organisms (13)